TAGRISSO 40 mg/1
osimertinib · TABLET, FILM COATED · AstraZeneca Pharmaceuticals LP
No Recall History
Plain English
TAGRISSO is a tablet, film coated containing osimertinib at 40 mg/1, taken oral. Manufactured by AstraZeneca Pharmaceuticals LP.
Key Facts
- Brand Name
- TAGRISSO
- Generic Name
- osimertinib
- NDC Code (Product)
0310-1248- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 40 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA208065
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 11/13/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is TAGRISSO used for?
TAGRISSO contains osimertinib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is TAGRISSO a controlled substance?
TAGRISSO is not classified as a controlled substance by the DEA.
What is the generic name for TAGRISSO?
The generic name for TAGRISSO is osimertinib. There are no other listed brand versions of osimertinib.
What is the NDC code for TAGRISSO 40 mg/1?
The NDC (National Drug Code) for TAGRISSO 40 mg/1 is 0310-1248, listed by AstraZeneca Pharmaceuticals LP.
Other TAGRISSO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)